 Evolus Inc NASDAQ: EOLS has announced two newly published peer review studies in Aesthetic Surgery Journal that provide supportive evidence of the safety and efficacy of repeat doses of prabotulinumtoxinA Jeuveau to decrease the appearance of glabellar lines also known as frown lines between the eyes. The two Phase 2 studies demonstrate that prolonged use of Jeuveau is safe and effective with repeat treatments. 